文献速递血液净化与透析肾移植

瑞典全国队列:透析与肾移植患者COVID-19疫苗接种前后结局

Results of the first nationwide cohort study of outcomes in dialysis and kidney transplant patients before and after vaccination for COVID-19.
PubMed 文献 · Nephrol Dial Transplant · 2023-01-01

疫苗接种开始后,透析患者第三波(2021年4月)全因死亡率回落至COVID-19前水平,而移植受者死亡率仍升高;透析患者疫情早期住院和死亡风险高于移植受者,接种后风险低于移植受者。

要点

  • 疫苗接种前透析患者COVID-19住院和死亡风险高于肾移植受者(aOR 2.1),接种后风险低于移植受者(aOR 0.5)。
  • 疫苗接种开始后透析患者第三波全因死亡率回落至COVID-19前水平,移植受者仍升高。
  • 瑞典对肾脏替代治疗患者早期优先接种疫苗可能挽救了许多生命。

核心结论

  • 瑞典COVID-19大流行导致肾脏替代治疗患者死亡和住院率增加;疫苗接种开始后透析患者住院和死亡率明显下降,但移植受者未见下降。

主要发现

  • 2020年1月1日透析患者4097例(中位年龄70岁),肾移植受者5905例(中位年龄58岁)。
  • 2020年3月至2021年2月,透析患者平均全因死亡率较2019年同期升高10%(从720例增至804例死亡),移植受者升高22%(从158例增至206例死亡)。
  • 疫苗接种开始后,透析患者第三波(2021年4月)全因死亡率回落至COVID-19前水平,移植受者死亡率仍升高。
  • 疫苗接种前透析患者COVID-19住院和死亡风险高于移植受者(aOR 2.1,95%CI 1.7-2.5),接种后风险低于移植受者(aOR 0.5,95%CI 0.4-0.7)。

临床怎么用

  • 瑞典对肾脏替代治疗患者早期优先接种COVID-19疫苗,可能挽救了许多生命。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients on kidney replacement therapy (KRT) have been identified as a vulnerable group during the coronavirus disease 2019 (COVID-19) pandemic. This study reports the outcomes of COVID-19 in KRT patients in Sweden, a country where patients on KRT were prioritized early in the vaccination campaign. METHODS: Patients on KRT between January 2019 and December 2021 in the Swedish Renal Registry were included. Data were linked to national healthcare registries. The primary outcome was monthly all-cause mortality over 3 years of follow-up. The secondary outcomes were monthly COVID-19-related deaths and hospitalizations. The results were compared with the general population using standardized mortality ratios. The difference in risk for COVID-19-related outcomes between dialysis and kidney transplant recipients (KTRs) was assessed in multivariable logistic regression models before and after vaccinations started. RESULTS: On 1 January 2020, there were 4097 patients on dialysis (median age 70 years) and 5905 KTRs (median age 58 years). Between March 2020 and February 2021, mean all-cause mortality rates increased by 10% (from 720 to 804 deaths) and 22% (from 158 to 206 deaths) in dialysis and KTRs, respectively, compared with the same period in 2019. After vaccinations started, all-cause mortality rates during the third wave (April 2021) returned to pre-COVID-19 mortality rates among dialysis patients, while mortality rates remained increased among transplant recipients. Dialysis patients had a higher risk for COVID-19 hospitalizations and death before vaccinations started {adjusted odds ratio [aOR] 2.1 [95% confidence interval (CI) 1.7-2.5]} but a lower risk after vaccination [aOR 0.5 (95% CI 0.4-0.7)] compared with KTRs. CONCLUSIONS: The COVID-19 pandemic in Sweden resulted in increased mortality and hospitalization rates among KRT patients. After vaccinations started, a distinct reduction in hospitalization and mortality rates was observed among dialysis patients, but not in KTRs. Early and prioritized vaccinations of KRT patients in Sweden probably saved many lives.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Wijkström J, Caldinelli A, Bruchfeld A, et al. Results of the first nationwide cohort study of outcomes in dialysis and kidney transplant patients before and after vaccination for COVID-19. Nephrol Dial Transplant. 2023. PMID: 37433606. doi:10.1093/ndt/gfad151

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。